| 000 | 00998 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518001750.0 | ||
| 264 | 0 | _c20190830 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.14921 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Cheng-Yuan | |
| 245 | 0 | 0 |
_aEditorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c10 2018 |
||
| 300 |
_a875-876 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aHepatitis B e Antigens |
| 650 | 0 | 4 | _aHepatitis B, Chronic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon-alpha |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 48 _gno. 8 _gp. 875-876 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.14921 _zAvailable from publisher's website |
| 999 |
_c28900544 _d28900544 |
||